Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 31 July, 2020

UBS ETFs

UBS ETF SICAV - Dividend Declaration - UKdis

RNS Number : 6850U
UBS ETFs
31 July 2020
 

UBS ETF

Société d'Investissement à Capital Variable

Registered Office: 49, Avenue J.F. Kennedy, L - 1855 Luxembourg

R.C.S.  Luxembourg No. B 83.626

 

 

NOTICE TO SHAREHOLDERS

 

 

The Board of Directors of UBS ETF, SICAV has decided to proceed with the interim distribution of dividends for certain of its sub-funds in respect of the financial year 2020.

 

 

With record date of 31 July 2020, ex-date of 03 August 2020 and payment date of 06 August 2020:

 

Share Class Name

ISIN

Currency

Dividend per share

UBS ETF - MSCI Emerging Markets UCITS ETF (USD) A-UKdis

LU1126036976

USD

0.1244

UBS ETF - MSCI EMU UCITS ETF (EUR) A-Ukdis

LU1107559376

EUR

0.2312

UBS ETF - MSCI Japan UCITS ETF (JPY) A-UKdis

LU1107559616

JPY

16.2982

UBS ETF - MSCI Pacific (ex Japan) UCITS ETF (USD) A-UKdis

LU1107559707

USD

0.1829

UBS ETF - MSCI Switzerland 20/35 UCITS ETF (CHF) A-UKdis

LU1107560036

CHF

0.2669

UBS ETF - MSCI United Kingdom UCITS ETF (GBP) A-UKdis

LU1107559533

GBP

0.1659

UBS ETF - MSCI USA UCITS ETF (USD) A-UKdis

LU1107559889

USD

0.1658

 

 

With record date of 31 July 2020, ex-date of 04 August 2020 and payment date of 06 August 2020:

 

Share Class Name

ISIN

Currency

Dividend per share

UBS ETF - MSCI Canada UCITS ETF (CAD) A-UKdis

LU1107559962

CAD

0.1861

 

 

The payments will be done by the Central Administration:

 

State Street Bank International GmbH, Luxembourg Branch

49, Avenue J.F. Kennedy

L-1855 Luxembourg

 

 

 

 

 

Or by the Paying Agent in Switzerland:

 

UBS Switzerland AG

Bahnhofstrasse 45, CH-8098 Zurich

and their branches in Switzerland

 

 

 

The Board of Directors

Luxembourg, July 31, 2020.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVKKKBNCBKDFON

a d v e r t i s e m e n t